Dr. Stephen White named recipient of 2022 AVMA Clinical Research Award
(SCHAUMBURG, Illinois) August 4, 2022—The American Veterinary Medical Association (AVMA) today named Dr. Stephen White, Distinguished Professor at the University of California-Davis School of Veterinary Medicine, as the winner of the 2022 AVMA Clinical Research Award.
Established in 1955 by the AVMA Council on Research, the award is given annually to an AVMA member who has made significant contributions to the diagnosis, prevention or treatment of diseases in animals, including the study of mechanisms of disease, therapeutic interventions, clinical trials, development of new technologies and epidemiological studies.
“Dr. White’s decades’-long career in publishing impactful clinical research has had a tremendous influence in advancing the diagnosis, treatment and prevention of dermatological conditions in animals,” said Dr. Lori Teller, president of the AVMA. “Dr. White has contributed substantially to the body of knowledge in clinical veterinary dermatology across multiple species, influencing the practice of veterinary dermatology in both small animal and large animal clinical practice, and he is well deserving of this recognition.”
Throughout his career, Dr. White has taken a collaborative approach to advancing knowledge in veterinary dermatology. This collaboration has included colleagues in other veterinary disciplines or in other countries, and many of his large retrospective studies characterizing skin disease in various species have involved colleagues at other veterinary schools or in other parts of the world to increase the number of cases reviewed and to increase the impact of the research. These collaborations have increased veterinary medicine’s understanding of skin diseases in several species in which there was limited prior knowledge, and have provided valuable clinical information for therapies now being used in human dermatology.
Over the course of his career, Dr. White has published more than 100 papers in peer-reviewed journals, which have strongly influenced how veterinarians manage many dermatological diseases today; for example, the use of a tetracycline and niacinamide to treat sterile inflammatory and autoimmune skin diseases. These studies have broadened the profession’s knowledge of many dermatologic disorders in various species, particularly equine and exotic animals. In addition to these studies, Dr. White has also written 56 book chapters and five review articles in peer-reviewed veterinary journals.
Dr. White has educated numerous veterinary students and visitor scholars from various parts of the world throughout his career, and contributed to the training of more than 20 residents. He is a well-known and respected speaker nationally and internationally, delivering nearly 400 presentations around the world, attesting to the international recognition of his remarkable contributions to veterinary dermatology
Dr. White has previously been honored with the American Academy of Veterinary Dermatology Frank Král Award for Achievements in Veterinary Dermatology, the American College of Veterinary Dermatology Award of Excellence, the World Association for Veterinary Dermatology Appreciation Award, and Honorary Lifetime Membership at the British Veterinary Dermatology Study Group.
For more information, contact Michael San Filippo, media relations manager, at 847-732-6194 (cell) or msanfilippoavma [dot] org (msanfilippo[at]avma[dot]org).
Serving more than 100,000 member veterinarians, the AVMA is the nation's leading representative of the veterinary profession, dedicated to improving the health and wellbeing of animals, humans and the environment. Founded in 1863 and with members in every U.S. state and territory and more than 60 countries, the AVMA is one of the largest veterinary medical organizations in the world. Informed by our members' unique scientific training and clinical knowledge, the AVMA supports the crucial work of veterinarians and advocates for policies that advance the practice of veterinary medicine and improve animal and human health.